Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc-fda/ and changes regularly. See the Directory of published versions
Draft as of 2024-10-30 |
{
"resourceType" : "ValueSet",
"id" : "pqcmc-specification-type-terminology",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet pqcmc-specification-type-terminology</b></p><a name=\"pqcmc-specification-type-terminology\"> </a><a name=\"hcpqcmc-specification-type-terminology\"> </a><a name=\"pqcmc-specification-type-terminology-en-US\"> </a><ul><li>Include these codes as defined in <a href=\"CodeSystem-cmc-ncit-dummy.html\"><code>http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ncit-dummy</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"CodeSystem-cmc-ncit-dummy.html#cmc-ncit-dummy-C134021\">C134021</a></td><td>Drug Product</td></tr><tr><td><a href=\"CodeSystem-cmc-ncit-dummy.html#cmc-ncit-dummy-C134022\">C134022</a></td><td>Drug Substance</td></tr><tr><td><a href=\"CodeSystem-cmc-ncit-dummy.html#cmc-ncit-dummy-C133931\">C133931</a></td><td>Raw Materials/Excipients/Intermediates/Reagents</td></tr></table></li></ul></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "brr"
}
],
"url" : "http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-specification-type-terminology",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.4.642.40.36.48.24"
}
],
"version" : "1.0.0",
"name" : "PqcmcSpecificationTypeTerminology",
"title" : "Specification Type Terminology",
"status" : "draft",
"experimental" : false,
"date" : "2024-10-30T15:40:50+00:00",
"publisher" : "HL7 International / Biomedical Research and Regulation",
"contact" : [
{
"name" : "HL7 International / Biomedical Research and Regulation",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/rcrim"
},
{
"system" : "email",
"value" : "brr@lists.HL7.org"
}
]
}
],
"description" : "Terminology used to qualify the information pertaining to specification types in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US",
"display" : "United States of America"
}
]
}
],
"compose" : {
"include" : [
{
"system" : "http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ncit-dummy",
"concept" : [
{
"code" : "C134021",
"display" : "Drug Product"
},
{
"code" : "C134022",
"display" : "Drug Substance"
},
{
"code" : "C133931",
"display" : "Raw Materials/Excipients/Intermediates/Reagents"
}
]
}
]
}
}